Speakers
Andreas Brueckner
Quantitative Safety Scientist, Novartis Pharma AG, Switzerland
Andreas received a Master degree in Stats from the University of Dortmund. He initially worked as project leader for diabetes drugs. He has worked in pharmacovigilance and was involved in signal detection and spontaneous reports analysis. He is responsible for integrated analyses in the TA oncology.
Joachim Vollmar, MSc
Executive Consultant, International Clinical Development Consultants LLC (ICDC), United States
Joachim Vollmar, a trained mathematician and certified bistatistician, has more than 40 years of experience in preclinical and clinical research and development of drugs, biologics, medical devices and diagnostics. After 22 years in the pharmaceutical industry, and 12 years with a CRO, he has been involved in innumerable projects, acting as chairman and member of Data Monitoring Committees, serving as an executive statistical, drug safety, scientific and management consultant for the health care industry in North America and Europe. He founded International Clinical Development Consultants (ICDC), an independent consultancy and co-founded PRESCOS, a preclinical research and scientific consulting services organization.
Have an account?